bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Iovance Biotherapeutics Inc. logo

    Iovance Biotherapeutics Inc.

    IOVA | NASDAQ
    Chart Builder DCF Calculator
    $10.19
    -$0.06 (-0.59%)
    At close: Sep 21, 2026, 4:00 PM ET
    $10.24
    +$0.05 (+0.49%)
    Pre-market: Sep 22, 2026, 6:27 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $4.58B
    Enterprise Value
    $4.3B
    Beta
    0.70
    Average Volume
    15.97M
    Shares Outstanding (Diluted)
    450.19M
    Shares Change YoY
    34.58%
    Institutional Ownership
    64.30%
    Exchange
    NASDAQ
    ISIN
    US4622601007

    Price Performance

    Price Change 1M
    26.3%
    Price Change 3M
    129.5%
    Price Change 6M
    171.7%
    Price Change YTD
    304.4%
    Price Change 1Y
    380.7%
    Price Change 3Y
    109.2%
    Price Change 5Y
    -59.2%
    1M CAGR (ann.)
    65.1%
    1Y CAGR (ann.)
    361.7%
    5Y CAGR (ann.)
    -14.8%
    All-Time CAGR
    -13.8%

    Valuation

    PE Ratio
    -14.56
    Forward PE
    N/A
    PEG Ratio
    -0.24
    Forward PEG
    0.28
    PS Ratio
    14.00
    Forward PS
    8.20
    PB Ratio
    6.18
    P/FCF Ratio
    -15.35
    P/Adj. FCF Ratio
    -13.26
    P/OCF Ratio
    -17.27
    EV/Sales
    13.23
    EV/EBIT
    -14.63
    EV/EBITDA
    -16.36
    EV/FCF
    -14.50
    Earnings Yield
    -6.9%
    FCF Yield
    -6.5%
    Adj. FCF Yield
    -7.5%

    Financial Health

    Net Cash
    $297.67M
    Total Debt
    $46M
    Cash & Short-Term Investments
    $297.67M
    Total Assets
    $915.53M
    Current Ratio
    4.35
    Quick Ratio
    3.82
    Debt / Equity Ratio
    0.06
    Debt / EBITDA
    -0.18
    Debt / FCF
    -0.16
    OCF / Debt
    -5.74
    Interest Coverage
    0.00
    Altman Z-Score
    10.63
    Piotroski F-Score
    5

    Margins & Profitability

    Gross Profit Margin
    116.3%
    Operating Profit Margin
    -92.7%
    EBITDA Margin
    -80.9%
    Net Profit Margin
    -89.1%
    FCF Margin
    -91.2%
    Adj. FCF Margin
    -105.6%
    SBC / Revenue
    14.4%
    SBC Impact (per share)
    -15.8%

    Returns

    Return on Assets
    -31.6%
    Return on Equity
    -40.5%
    Return on Invested Capital
    -36.6%
    Return on Capital Employed
    -37.3%
    Return on Tangible Assets
    -44.4%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    1009.4%
    Revenue CAGR 5Y
    74.3%
    Revenue CAGR 10Y
    48.3%
    EPS CAGR 3Y
    40.4%
    EPS CAGR 5Y
    26.6%
    EPS CAGR 10Y
    3.7%
    FCF CAGR 3Y
    15.3%
    FCF CAGR 5Y
    0.9%
    FCF CAGR 10Y
    -13.9%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    21
    EPS Growth Next 3Y
    42.9%
    Revenue Growth Next 3Y
    48.6%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$0.12
    EPS Growth Est (next Q)
    -52.0%
    Revenue Est (next Q)
    $110.12M
    Revenue Growth Est (next Q)
    63.2%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $8.17
    Price Target Upside
    -19.8%

    Cash Flow

    Operating Cash Flow
    $-264.18M
    Free Cash Flow
    $-296.4M
    Adj. Free Cash Flow
    $-343.11M
    FCF Per Share
    -$0.66
    OCF Per Share
    -$0.59
    OCF/S Ratio
    -81.3%

    Income Statement

    Revenue
    $324.97M
    Gross Profit
    $377.94M
    Operating Income
    $-301.31M
    EBITDA
    $-262.8M
    Net Income
    $-289.52M
    EPS (Diluted)
    -$0.70
    Revenue / Employee
    $333.3K
    Profit / Employee
    $-296.94K
    Employees
    975

    © 2026 bestshares.com. All rights reserved.